Skip to main content
logo
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.09
+0.06 (1.19%)
Aug 18, 2026, 4:00 PM EDT - Market closed

Champions Oncology Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Revenue
59.4356.9450.1653.8749.11
Revenue Growth
4.36%13.54%-6.90%9.70%19.66%
Cost of Revenue
30.928.3929.429.5323.63
Gross Profit
28.5328.5620.7524.3425.48
Selling, General & Admin
20.4716.8818.1317.2415.5
Research & Development
9.086.839.5411.559.37
Operating Expenses
29.5523.7127.6828.7924.87
Operating Income
-1.034.85-6.92-4.450.61
Interest Expense
---0.03--
Interest & Investment Income
--0.09--
Currency Exchange Gain (Loss)
---0.02-0.01-0.02
Other Non Operating Income (Expenses)
0.210.07---
EBT Excluding Unusual Items
-0.824.92-6.87-4.460.58
Gain (Loss) on Sale of Assets
-0.11-0.29-0.44--
Asset Writedown
----0.81-
Pretax Income
-0.934.63-7.31-5.270.58
Income Tax Expense
0.25-0.08-0.030.070.04
Net Income
-1.184.7-7.28-5.340.55
Net Income to Common
-1.184.7-7.28-5.340.55
Net Income Growth
----51.38%
Shares Outstanding (Basic)
1414141413
Shares Outstanding (Diluted)
1414141414
Shares Change
-3.04%5.31%0.04%-4.37%-2.84%
EPS (Basic)
-0.080.34-0.54-0.390.04
EPS (Diluted)
-0.080.33-0.54-0.390.04
EPS Growth
----100.01%

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Free Cash Flow
-5.047-6.971.14.11
Free Cash Flow Per Share
-0.360.49-0.520.080.29
Gross Margin
48.00%50.15%41.38%45.18%51.88%
Operating Margin
-1.73%8.51%-13.80%-8.26%1.24%
Profit Margin
-1.98%8.25%-14.51%-9.90%1.12%
Free Cash Flow Margin
-8.48%12.29%-13.90%2.04%8.38%
EBITDA
0.356.49-5.05-2.832.23
EBITDA Margin
0.59%11.39%-10.08%-5.26%4.55%
D&A For EBITDA
1.381.641.871.621.63
EBIT
-1.034.85-6.92-4.450.61
EBIT Margin
-1.73%8.51%-13.80%-8.26%1.24%
Effective Tax Rate
----6.00%
SEC Filings: 10-K · 10-Q